Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Propionate (OPN-375) in Bilateral Nasal Polyposis
NCT01624662Phase 3Completed
- Sponsor
- OptiNose
- Start
- Oct 2013
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate in nasal polyps, sponsored by OptiNose. Started Oct 2013; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT01624662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01624662.